You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 5,006,528


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,006,528
Title: Carbostyril derivatives
Abstract:A novel carbostyril derivative and salt thereof represented by the formula (1) ##STR1## (wherein R is a group of the formula ##STR2## ((wherein R.sup.1 is a C.sub.1- C.sub.3 alkoxy group)), a group of the formula ##STR3## ((wherein R.sup.2 and R .sup.3 are each, at the same time, a chlorine atom, a bromine atom; and R.sup.4 is a hydrogen atom or a chlorine atom)), 2-methyl-3-nitrophenyl group, 3,5-dichlorophenyl group, or a group of the formula ##STR4## ((wherein R.sup.5 is a chlorine atom or a bromine atom; and R.sup.6 is a methyl group)); the carbon-carbon bond between 3- and 4-position in the carbostyril skeleton is a single or double bond).
Inventor(s): Oshiro; Yasuo (Tokushima, JP), Sato; Seiji (Itano, JP), Kurahashi; Nobuyuki (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:07/424,719
Patent Claims: 1. A carboxtyril compound or salt thereof of the formula, ##STR34## wherein R is a group of the formula ##STR35## wherein R.sup.1 is a C.sub.1 -C.sub.3 alkoxy group; a group of the formula ##STR36## wherein R.sup.2 and R.sup.3 are at the same time, both chlorine atoms, or both bromine atoms and R.sup.4 is a hydrogen atom or a chlorine atom; a 2-methyl-3-nitrophenyl group; a 3,5-dichlorophenyl group; or a group of the formula ##STR37## wherein R.sup.5 is a chlorine atom or a bromine atom and R.sup.6 is a methyl group; the carbon-carbon bond between the 3- and 4-positions in the carboxtyril skeleton being a single or a double bond.

2. The carboxtyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR38##

3. The carboxtyril compound or salt thereof of claim 2, wherein R.sup.1 is a methoxy group or an ethoxy group.

4. The carboxtyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR39##

5. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2 and R.sup.3 are chlorine atoms and R.sup.4 is a hydrogen atom.

6. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2 and R.sup.3 are bromine atoms and R.sup.4 is a hydrogen atom.

7. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2, R.sup.3 and R.sup.4 are chlorine atoms.

8. The carbostyril compound or salt thereof of claim 1, wherein R is a 2-methyl-3-nitrophenyl group or a 3,5-dichlorophenyl group.

9. The carbostyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR40##

10. The carbostyril compound or salt thereof of claim 9, wherein R.sup.5 is a chlorine atom.

11. The carbostyril compound or salt thereof of claim 9, wherein R.sup.5 is a bromine atom.

12. 7-{4-[4-(2,3 -Dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

13. 7-{4-[4-(b 2,3-Dichlorophenyl)-1-piperazinyl]-butoxy}carbostyril.

14. 7-{4-[4-(2-Ethoxyphenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

15. 7-{4-[4-]2-Ethoxyphenyl)-1-piperazinyl]butoxy}-carbostyril.

16. A pharmaceutical composition for treating schizophrenia containing, as the active ingredient, a carbostyril compound or pharmaceutically acceptable salt thereof of claim 1 and a pharmaceutically acceptable carrier.

17. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

18. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}carbostyril.

19. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2-ethoxyphenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

20. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2-ethoxyphenyl)-1-piperazinyl]butoxy}carbostyril.

21. The pharmaceutical composition for treating schizophrenia containing, as the active ingredient, a carbostyril compound or pharmaceutically acceptable salt thereof of claim 3 and a pharmaceutically acceptable carrier.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.